Teva’s migraine drug Ajovy (fremanezumab) has been approved in Europe, taking on rivals from the same class from Novartis and Eli Lilly. Novartis already has Aimovig (erenumab) approved in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback